author-photo

Jody C. Chuang

Stanford University

9

Papers

126

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy

2018 Journal of Thoracic Disease
Show All
- Source
- Cite
- Save
Citations (2)
ERBB2-Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (54)
Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions

2016 Expert Opinion on Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (15)
Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

2016 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (7)
Crizotinib as first line therapy for advanced ALK -positive non-small cell lung cancers

2015 Translational lung cancer research
- Jody C. Chuang
- Joel W. Neal
Show All
- Source
- Cite
- Save
Citations (14)